Low density and high affinity of platelet [3H]paroxetine binding in women with bulimia nervosa

Psychiatry Research

Volumn 142, Issue 2-3, 2006, Pages 219-223

  Ekman, Agneta ^a   Sundblad Elverfors, Charlotta ^a   Landén, Mikael ^b   Eriksson, Tomas ^c   Eriksson, Elias ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

3H paroxetine binding; Bmax; Bulimia nervosa; Kd; Platelets; Serotonin transporter; Women

Indexed keywords

LIGAND; PAROXETINE; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BINDING AFFINITY; BINDING SITE; BULIMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISSOCIATION CONSTANT; EATING DISORDER; FEMALE; HUMAN; PRIORITY JOURNAL; THROMBOCYTE;

ADULT; BLOOD PLATELETS; BRAIN; BULIMIA; FEMALE; HUMANS; PAROXETINE; RADIOLIGAND ASSAY; REFERENCE VALUES; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRITIUM;

EID: 33646851374     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2006.02.012     Document Type: Article

References (31)

1. Alvarez J.C., Gluck N., Arnulf I., Quintin P., Leboyer M., Pecquery R., Launay J.M., Perez-Diaz F., and Spreux-Varoquaux O. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine. Clinical Pharmacology and Therapeutics 66 (1999) 617-624
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed (DSM-IV) (1994), APA, Washington, DC
3. Arnold L.M., McElroy S.L., Hudson J.I., Welge J.A., Bennett A.J., and Keck P.E. A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. Journal of Clinical Psychiatry 63 (2002) 1028-1033
4. Brewerton T.D. Toward a unified theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinology 20 (1995) 561-590
5. Briley M.S., Langer S.Z., Raisman R., Sechter D., and Zarifian E. Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science 209 (1980) 303-305
6. Halmi K.A. Eating disorders in females: genetics, pathophysiology, and treatment. Journal of Pediatric Endocrinology 15 Suppl 5 (2002) 1379-1386
7. Jimerson D.C., Lesem M.D., and Kaye W.H. Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Archives of General Psychiatry 49 (1992) 132-138
8. Kaye W., Gendall K., and Strober M. Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa. Biological Psychiatry 44 (1998) 825-838
9. 3H-paroxetine to blood platelets in healthy volunteers: indications for a gender difference. Biological Psychiatry 28 (1990) 509-517
10. Kuikka J.T., Tammela L., Karhunen L., Rissanen A., Bergström K.A., Naukkarinen H., Vanninen E., Karhu J., Lappalainen R., Repo-Tiihonen E., Tiihonen J., and Uusitupa M. Reduced serotonin transporter binding in binge eating women. Psychopharmacology 155 (2001) 310-314
11. Leboyer M., Quintin P., Manivet P., Varoquaux O., Allilaire J.-F., and Launay J.-M. Decreased serotonin transporter binding in unaffected relatives of manic depressed patients. Biological Psychiatry 46 (1999) 1703-1706
12. Lesch K.P., Wolozin B.L., Murphy D.L., and Riederer P. Primary structure of the human platelet serotonin (5-HT) uptake site: identity with the brain 5-HT transporter. Journal of Neurochemistry 60 (1993) 2319-2322
13. Markwell M.A., Haas S.M., Bieber L.L., and Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Analytical Biochemistry 87 (1978) 206-210
14. Marazziti D., Macchi E., Rotondo A., Placidi G.F., and Cassano G.B. Involvement of serotonin system in bulimia. Life Sciences 43 (1988) 2123-2126
15. 3H-paroxetine binding in obsessive-compulsive patients. Neuropsychobiology 34 (1996) 184-187
16. 3H-paroxetine binding in untreated panic disorder patients. Life Sciences 65 (1999) 2735-2741
17. McElroy S.L., Casuto L.S., Nelson E.B., Lake K.A., Soutullo C.A., Keck Jr. P.E., and Hudson J.I. Placebo-controlled trial of sertraline in the treatment of binge eating disorder. American Journal of Psychiatry 157 (2000) 1004-1006
18. Mehler P.S. Bulimia nervosa. New England Journal of Medicine 349 (2003) 875-881
19. 3H]paroxetine binding in premenstrual dysphoria. Psychoneuroendocrinology 28 (2003) 446-458
20. Munson P.J., and Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Analytical Biochemistry 107 (1980) 220-239
21. Nemeroff C.B., Knight D.L., Franks J., Craighead W.E., and Krishnan K.R. Further studies on platelet serotonin transporter binding in depression. American Journal of Psychiatry 151 (1994) 1623-1625
22. Neuger J., Wistedt B., Sinner B., Åberg-Wistedt A., and Stain-Malmgren R. The effect of citalopram treatment on platelet serotonin function in panic disorders. International Clinical Psychopharmacology 15 (2000) 83-91
23. 2+ response, and 5-HT content in winter seasonal affective disorder. Biological Psychiatry 36 (1994) 458-466
24. 3H]citalopram binding to brain and platelet membranes of human and rat. Journal of Neurochemistry 56 (1991) 248-252
25. 3H]paroxetine binding in patients with eating disorders. Psychiatry Research 118 (2003) 33-38
26. Rojansky N., Halbreich U., Zander K., Barkai A., and Goldstein S. Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes. Gynecologic and Obstetric Investigation 31 (1991) 146-152
27. Sallee F.R., Richman H., Beach K., Sethuraman G., and Nesbitt L. Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 35 (1996) 1647-1656
28. Steiger H., Gauvin L., Israël M., Koerner N., Ng Ying Kin N.M.K., Paris J., and Young S.N. Association of serotonin and cortisol indices with childhood abuse in bulimia nervosa. Archives of General Psychiatry 58 (2001) 837-843
29. Steiger H., Young S.N., Ng Ying Kin N.M.K., Koerner N., Israël M., Lageix P., and Paris J. Implications of affective symptoms for serotonin function in bulimia nervosa. Psychological Medicine 31 (2001) 85-95
30. Steiger H., Gauvin L., Israël M., Ng Ying Kin N.M.K., Young S.N., and Roussin L. Serotonin function, personality-trait variations, and childhood abuse in women with bulimia-spectrum eating disorders. Journal of Clinical Psychiatry 64 (2004) 830-837
31. 123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biological Psychiatry 49 (2001) 326-332